JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

Neurology

Volumn 52, Issue 2, 1999, Pages 253-260

  Koralnik, I J ^a,b   Boden, D ^a   Mai, V X ^a   Lord, C I ^a   Letvin, N L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS DNA;

ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; JC VIRUS; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; URINALYSIS; VIRUS DETECTION; VIRUS LOAD;

EID: 0033555565     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.2.253     Document Type: Article

References (38)

1. Padgett BL, ZuRhein G, Walker D, Echroade R, Dessel B. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1:1257-1260.
2. Walker DL, Padgett BL. The epidemiology of human polyomaviruses. In: Sever JL, Madden D, ed. Polyomaviruses and human neurological disease. New York: Alan R. Liss, 1983:99-106.
3. Arthur RR, Dagostin S, Shah KV. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol 1989;27:1174-1179.
4. Kitamura T, Aso Y, Kuniyoshi N, Kara K, Yogo Y. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990;161:1128-1133.
5. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993;167:13-20.
6. Agostini HT, Ryschkewitsch CF, Stoner GT. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 1996;34:159-164.
7. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998;4:59-68.
8. Tornatore C, Berger JR, Houff SA, et al. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992;31:454-462.
9. Quinlivan EB, Norris M, Bouldin TW, et al. Subclinical central nervous system infection with JC virus in patients with AIDS. J Infect Dis 1992;166:80-85.
10. Dorries K, Vogel E, Gunther S, Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994;198:59-70.
11. Sundsfjord A, Flaegstad T, Flo R, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994;169:485-490.
12. Dubois V, Lafon ME, Ragnaud JM, et al. Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. AIDS 1996;10:353-358.
13. Azzi A, DeSantis R, Ciappi S, et al. Human Polyomaviruses DNA detection in peripheral blood leukocytes from immuno-competent and immunocompromised individuals. J Neurovirol 1996;2:411-416.
14. Perrons CJ, Fox JD, Lucas SB, Brink NS, Tedde RS, Miller RF. Detection of Polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease. J Infect Dis 1996;32:205-209.
15. Monaco MCG, Atwood WJ, Gravell M, Major EO. JCV infection of hematopoietic progenitor cells, primary B lymphocytes and tonsillar stromal cells: implications for viral latency. J Virol 1996;70:7004-7012.
16. Dubois V, Dutronc H, Lafon ME, et al. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1997;35: 2288-2292.
17. Gallia GL, Houff AH, Major EO, Khalili K. Review: JC virus infection of lymphocytes - revisited. J Infect Dis 1997;176: 1603-1609.
18. Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E, et al. Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy. J Med Virol 1997;52:235-242.
19. Degener AM, Pietropaolo V, Rizzuti V, et al. Detection of JC and BK viral genome in specimens of HIV-1 infected subjects. Microbiology 1997;20:115-122.
20. Gibson PE, Knowles WA, Hand JF, Brown DWG. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 1993; 39:278-281.
21. Moret H, Guichard M, Matheron S, et al. Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 1993;31:3310-3313.
22. Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994;8:49-57.
23. Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995;33:484-486.
24. McGuire D, Barhite S, Hollander H, Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-399.
25. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996;10:951-958.
26. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997;48: 687-694.
27. Olsen WL, Longo FM, Mills CM, Norman D. White matter disease in AIDS: findings at MR imaging. Radiology 1988;169: 445-448.
28. Frisque R, Bream G, Canella M. Human polyomavirus JC virus genome. J Virol 1984;51:458-469.
29. Huang SS, Skolasky RL, Dal Pan GJ, Royal W, McArthur JC. Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 1998;4:324-332.
30. Walker DL, Frisque RJ. The biology and molecular biology of JC virus. In: Salzman NP, ed. The papovaviridae. Vol. 1. New York: Plenum Press, 1986:327-377.
31. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like sequences in human pleural mesothelioma. Oncogene 1994;9: 1781-1790.
32. Clementi M, Menzo S, Manzin A, Bagnarelli P. Quantitative molecular methods in virology. Arch Virol 1995;140:1523-1539.
33. Houff SA, Major EO, Katz D, et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 1988;318:301-305.
34. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5:49-73.
35. Levy RM, Russel E, Yungbluth M, Frais Hidvegi D, Brody BA, Dal Canto MC. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome. Neurosurgery 1992;30:186-190.
36. Holloway RG, Mushlin AI. Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotaxic brain biopsy. Neurology 1996;46:1010-1015.
37. Vinters HV, Tomiyasu U, Anders KH. Neuropathologic complications of infection with the human immunodeficiency virus (HIV). Prog AIDS Pathol 1989;1:101-130.
38. Taoufik Y, Karaterki A, Gasnault J, et al. Quantitation of JC virus in CSF and urine: prognostic value of CSF JC viral load in patients with progressive multifocal leukoencephalopathy. Presented at the 12th World AIDS Conference; Geneva, Switzerland; June 30, 1998. Abstract no. 22266.